Tiotropium (Spiriva) Rehabilitation Study
Public ClinicalTrials.gov record NCT00274521. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo Controlled 25-week Trial to Compare the Effect of Tiotropium Inhalation Capsuled (18 Mcg) Once Daily on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 8 Weeks of Pulmonary Rehabilitation.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study was designed to determine whether tiotropium inhalation capsules, compared to placebo, enhances the improvement in exercise tolerance seen in patients with chronic obstructive pulmonary disease (COPD) who participate in pulmonary rehabilitation. In addition, assessments of the effect of tiotropium on dyspnea and quality of life following pulmonary rehabilitation were taken.
Study identification
- NCT ID
- NCT00274521
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 108 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2001 (Type not available)
- Primary completion
- Feb 2003 (Actual)
- Completion
- Not listed
- Last update posted
- Nov 1, 2013
Started 2001
United States locations
- U.S. sites
- 19
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | — | — |
| Boehringer Ingelheim Investigational Site | Phoenix | Arizona | — | — |
| Attention: John E. Hodgkin, M.D. | Deer Park | California | — | — |
| Boehringer Ingelheim Investigational Site | Long Beach | California | — | — |
| UCLA School of Medicine | Los Angeles | California | — | — |
| Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| Harbor-UCLA Research and Education Institute | Torrance | California | — | — |
| Boehringer Ingelheim Investigational Site | Fort Collins | Colorado | — | — |
| Boehringer Ingelheim Investigational Site | Wheat Ridge | Colorado | — | — |
| Boehringer Ingelheim Investigational Site | Danbury | Connecticut | — | — |
| St. Francis Hospital and Medical Center | Hartford | Connecticut | — | — |
| Norwalk Hospital | Norwalk | Connecticut | — | — |
| Boehringer Ingelheim Investigational Site | Elk Grove Village | Illinois | — | — |
| UMass Memorial Medical Center | North Worcester | Massachusetts | — | — |
| Henry Ford Hospital | Detroit | Michigan | — | — |
| University of Nebraska Medical Center | Omaha | Nebraska | — | — |
| Duke University Medical Center | Durhan | North Carolina | — | — |
| Temple University Hospital | Philadelphia | Pennsylvania | — | — |
| Boehringer Ingelheim Investigational Site | Everett | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00274521, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2013 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00274521 live on ClinicalTrials.gov.